bioRxivMolecular BiologyPreprint
Compound Screening with Deep Learning for Neglected Diseases: Leishmaniasis
Jonathan SmithiD, Hao XuiD, Xinran LiiD, Laurence YangiD, Jahir M. GutierreziD
Abstract
AO_SCPLOWBSTRACTC_SCPLOWDeep learning provides a tool for improving screening of candidates for drug re-purposing to treat neglected diseases. We show how a new pipeline can be developed to address the needs of repurposing for Leishmaniasis. In combination with traditional molecular docking techniques, this allows top candidates to be selected and analyzed, including for molecular descriptor similarity.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Drug repurposing for Leishmaniasis with Hyperbolic Graph Neural Networks
Yenson Lau, Jahir M. Gutierrez, … Saba Zuberi·bioRxiv·Feb 11, 2023
- A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism
- A machine learning and network framework to discover new indications for small molecules
C. Gilvary, J. Elkhader, … O. Elemento·bioRxiv·Aug 28, 2019
- In silico-based screening for natural products structural analogs as new drugs candidate against leishmaniasis
Haruna Luz Barazorda-Ccahuana, Luis Daniel Goyzueta-Mamani, … Miguel Á. Chávez‐Fumagalli·bioRxiv·Jul 22, 2022
- Deep Learning for Virtual Screening: Five Reasons to Use ROC Cost Functions
V. Golkov, A. Becker, … D. Cremers·bioRxiv·Jun 25, 2020
- Deep Learning-based Ligand Design using Shared Latent Implicit Fingerprints from Collaborative Filtering
Raghuram Srinivas, Niraj Verma, … Eric C. Larson·Journal of Chemical Information and ModelingPeer-reviewed·Apr 26, 2021